Skip to main content

Table 1 Clinical characteristics of the 85 patients prior to the first ASCT

From: Impact of tandem autologous stem cell transplantation and response to transplant in the outcome of multiple myeloma

  85 patients, n (%)
Type MM IgG kappa 34 (40.0%)
IgG Lambda 14 (16.5%)
IgA kappa 10 (11.8%)
IgA Lambda 8 (9.4%)
Gammopathy with two monoclonal components 4 (4.7%)
Light Chain MM 11 (12.9%)
Non Secretor MM 4 (4.7%)
ISS score I 15 (17.6%)
II 47 (55.3%)
III 20 (23.5%)
Unknown 3 (3.5%)
Durie-Salmon stage IA 7 (8.2%)
IIA 16 (8.8%)
IIIA 49 (57.6%)
IIB 3 (3.5%)
IIIB 10 (11.8%)
  1. Abbreviations: MMMultiple Myeloma; IgImmunoglobulin; ISSInternational Staging System.